Anika to Participate in Upcoming Investor Conferences
07 November 2023 - 10:05PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint
preservation company in early intervention orthopedics, today
announced that Dr. Cheryl Blanchard, President and Chief
Executive Officer and Michael Levitz, Executive Vice
President, Chief Financial Officer and Treasurer, will be
participating at the following investor conferences:
- The Stephens Annual Investment
Conference at the Grand Hyatt, Nashville, TN, on Wednesday,
November 15, 2023. The Company will host a live presentation
starting at 8:00 a.m. CT/9:00 a.m. ET. Management will be hosting
1x1 investor meetings the same day.
- The Piper Sandler 35th Annual
Healthcare Conference at the Lotte New York Palace on Wednesday,
November 29, 2023. The Company will host a live presentation
starting at 2:50 p.m. ET. Management will be hosting 1x1 investor
meetings the same day.
Webcasts of all events will be available in the Investor
Relations section of Anika’s website, www.anika.com. An
archive of the all the presentations will also be available on the
website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care. Leveraging our
core expertise in hyaluronic acid and implant solutions, we partner
with clinicians to provide minimally invasive products that restore
active living for people around the world. Our focus is on high
opportunity spaces within orthopedics, including Osteoarthritis
Pain Management, Regenerative Solutions, Sports Medicine and
Arthrosurface Joint Solutions, and our products are efficiently
delivered in key sites of care, including ambulatory surgery
centers. Anika’s global operations are headquartered outside of
Boston, Massachusetts. For more information about Anika, please
visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are
registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:Anika Therapeutics,
Inc.Mark Namaroff, 781-457-9287Vice President, Investor Relations,
ESG and Corporate Communicationsinvestorrelations@anika.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
Von Jan 2024 bis Jan 2025